Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: early in vivo cardiovascular effects
Document
Academic Article
Generically Dependent Continuant
RDF description of Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: early in vivo cardiovascular effects - http://irises.unibs.it/resource/item/104800
Article
Information Content Entity